News Updates

More Articles Back to Article

MHRA approves Moderna's updated COVID-19 vaccine

Moderna announced that its COVID-19 vaccine, Spikevax, which has been updated to target the XBB.1.5 Omicron variant, has gained the Medicines and Healthcare products Regulatory Agency approval for use in persons ages 6 months and older. The company also disclosed that it will decrease production of mRNA drug substances at Lonza's facility in Switzerland due to reduced post-pandemic demand of the vaccines. Reuters (9/19)

Read full article now.

Articles are only one benefit of being a DIA member. Learn more and join today so you don’t miss another article!